A detailed history of Aspiriant, LLC transactions in Ishares Core S&P U.S. Value Et stock. As of the latest transaction made, Aspiriant, LLC holds 2,860,399 shares of IUSV stock, worth $267 Million. This represents 10.3% of its overall portfolio holdings.

Number of Shares
2,860,399
Previous 2,755,107 3.82%
Holding current value
$267 Million
Previous $249 Million 1.17%
% of portfolio
10.3%
Previous 10.33%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$85.39 - $90.42 $8.99 Million - $9.52 Million
105,292 Added 3.82%
2,860,399 $252 Million
Q1 2024

Apr 15, 2024

BUY
$82.87 - $90.44 $27.2 Million - $29.7 Million
328,238 Added 13.53%
2,755,107 $249 Million
Q4 2023

Jan 26, 2024

BUY
$71.48 - $84.61 $7.5 Million - $8.88 Million
104,918 Added 4.52%
2,426,869 $205 Million
Q3 2023

Oct 17, 2023

BUY
$74.38 - $81.04 $2.91 Million - $3.17 Million
39,080 Added 1.71%
2,321,951 $173 Million
Q2 2023

Jul 19, 2023

SELL
$72.65 - $78.26 $1.59 Million - $1.72 Million
-21,930 Reduced 0.95%
2,282,871 $179 Million
Q1 2023

Apr 27, 2023

BUY
$70.21 - $77.86 $165,274 - $183,282
2,354 Added 0.1%
2,304,801 $170 Million
Q4 2022

Jan 23, 2023

SELL
$68.46 - $73.93 $13.8 Million - $14.9 Million
-202,021 Reduced 8.07%
2,302,447 $0
Q3 2022

Oct 28, 2022

BUY
$64.77 - $73.64 $567,903 - $645,675
8,768 Added 0.35%
2,504,468 $157 Million
Q2 2022

Jul 25, 2022

BUY
$64.88 - $77.18 $13,884 - $16,516
214 Added 0.01%
2,495,700 $167 Million
Q1 2022

May 06, 2022

BUY
$71.81 - $77.49 $3.43 Million - $3.71 Million
47,823 Added 1.95%
2,495,486 $189 Million
Q4 2021

Feb 14, 2022

SELL
$71.13 - $76.45 $3.76 Million - $4.04 Million
-52,806 Reduced 2.11%
2,447,663 $187 Million
Q3 2021

Oct 27, 2021

SELL
$69.93 - $74.13 $237,342 - $251,597
-3,394 Reduced 0.14%
2,500,469 $177 Million
Q2 2021

Aug 13, 2021

BUY
$69.41 - $73.87 $17.8 Million - $19 Million
257,149 Added 11.45%
2,503,863 $180 Million
Q1 2021

May 11, 2021

BUY
$61.28 - $69.6 $3.94 Million - $4.47 Million
64,284 Added 2.95%
2,246,714 $155 Million
Q4 2020

Feb 01, 2021

BUY
$53.17 - $62.19 $7.5 Million - $8.77 Million
141,092 Added 6.91%
2,182,430 $136 Million
Q3 2020

Oct 29, 2020

BUY
$51.46 - $57.08 $46.2 Million - $51.3 Million
898,447 Added 78.61%
2,041,338 $111 Million
Q2 2020

Aug 06, 2020

BUY
$44.04 - $57.88 $6.37 Million - $8.37 Million
144,590 Added 14.48%
1,142,891 $59.7 Million
Q1 2020

May 05, 2020

BUY
$39.87 - $63.83 $4.19 Million - $6.71 Million
105,058 Added 11.76%
998,301 $46.1 Million
Q4 2019

Jan 27, 2020

BUY
$55.95 - $63.08 $73,798 - $83,202
1,319 Added 0.15%
893,243 $56.3 Million
Q3 2019

Nov 04, 2019

SELL
$54.3 - $58.65 $1.49 Million - $1.61 Million
-27,523 Reduced 2.99%
891,924 $51.5 Million
Q2 2019

Aug 06, 2019

BUY
$52.68 - $57.18 $1.04 Million - $1.13 Million
19,783 Added 2.2%
919,447 $52.1 Million
Q1 2019

May 03, 2019

BUY
$48.21 - $55.66 $1.72 Million - $1.99 Million
35,762 Added 4.14%
899,664 $49.3 Million
Q4 2018

Feb 04, 2019

SELL
$46.36 - $56.72 $1.93 Million - $2.36 Million
-41,638 Reduced 4.6%
863,902 $42.4 Million
Q3 2018

Oct 26, 2018

SELL
$53.63 - $57.68 $2.3 Million - $2.47 Million
-42,863 Reduced 4.52%
905,540 $51.1 Million
Q2 2018

Aug 07, 2018

SELL
$51.95 - $55.12 $3.11 Million - $3.3 Million
-59,925 Reduced 5.94%
948,403 $50.9 Million
Q1 2018

May 04, 2018

BUY
$51.81 - $58.63 $33.7 Million - $38.1 Million
649,880 Added 181.3%
1,008,328 $53.6 Million
Q4 2017

Jan 31, 2018

SELL
$52.55 - $55.6 $46.3 Million - $48.9 Million
-880,152 Reduced 71.06%
358,448 $19.9 Million
Q3 2017

Nov 13, 2017

BUY
$52.0 - $52.35 $64.4 Million - $64.8 Million
1,238,600
1,238,600 $64.8 Million

Others Institutions Holding IUSV

About ISHARES CORE S&P U.S. VALUE ET


  • Ticker IUSV
  • Sector ETFs
  • Industry ETFs
More about IUSV
Track This Portfolio

Track Aspiriant, LLC Portfolio

Follow Aspiriant, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.